Citigroup Inc news

   Watch this stock
Showing stories 1 - 10 of about 113   

Articles published

C 48.89 +0.27 (0.56%)
price chart
Citigroup: CCAR, QE And Notes From Fixed Income Call
Citi's CFO and Treasurer provided additional important disclosures relating to Citigroup's operations in the traditional fixed income call.
Citigroup Should Begin To Under-Promise And Over-Deliver (C)
Over-promising and under-delivering has plagued the company in the past and that's why it has remained stagnant for the past four years.
Stock Insights on Citigroup Inc (NYSE:C)
Citigroup Inc (NYSE:C) (TREND ANALYSIS) is expected to report earnings per share of $5.32 for the current fiscal year, as per consensus of analysts.
Stocks in Considerable Figures: FXCM Inc. (NYSE:FXCM), The Blackstone ...  eMarketsDaily
Bank of America Corp, Citigroup Inc, Wells Fargo & Co, JPMorgan Chase & Co ...
As of January 17, the group was already down 11% year to date, compared to a 3% drop in the S&P 500. The big four U.S. banks - Bank of America Corp.
Trade of the Day: Technicals Say JPM has Much Further to Fall  Investorplace.com
Citigroup Inc Earnings: Profit Plunges Higher Legal Costs and Lower Trading ...
This morning, Citigroup (NYSE: C ) became of third big bank to miss profit targets for the fourth quarter of 2014 thanks to a large increase in legal expenses and lower revenue from trading.
Citigroup Too Cheap To Pass Up  Seeking Alpha
Citigroup Inc (NYSE:C) Trading Outlook  Live Trading News
NuStar Energy L.P. Price Target Raised to $65.00 at Citigroup Inc. (NS)
NuStar Energy L.P. (NYSE:NS) had its price objective hosited by Citigroup Inc. from $59.00 to $65.00 in a report released on Monday.
Citigroup Inc. Cuts Spectra Energy Corp. Price Target to $37.00 (SE)  sleekmoney
NuStar Energy L.P. PT Raised to $65.00 at Citigroup Inc. (NS)  Ticker Report
USD Partners Price Target Lowered to $15.50 at Citigroup Inc. (USDP)
Research analysts at Citigroup Inc. dropped their price objective on shares of USD Partners (NASDAQ:USDP) from $19.00 to $15.50 in a report released on Monday.
The Medicines Company Price Target Raised to $30.00 at Citigroup Inc. (MDCO)
The Medicines Company logo Citigroup Inc. boosted their price target on shares of The Medicines Company (NASDAQ:MDCO) from $27.00 to $30.00 in a research note issued on Monday.
Ventas Price Target Increased to $83.00 by Analysts at Citigroup Inc. (VTR)
Ventas (NYSE:VTR) had its price target upped by Citigroup Inc. from $56.85 to $83.00 in a research note issued to investors on Monday.
Citigroup Inc. Boosts Ventas Price Target to $83.00 (VTR)  Intercooler
First Call Rating Update on Citigroup Inc
Citigroup Inc (NYSE:C): First Call has given a rating of Buy to Citigroup Inc, according to the consensus released by the firm.